Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04149600 · ClinicalTrials.gov registry record

Identification of Genetic Causes of Calcific Aortic Valve Disease

A clinical trial of Aortic Valve Disease and Aortic Aneurysm, sponsored by Beth Israel Deaconess Medical Center.

Active
Registry status
1,000
Enrollment target
1
Study location

NCT04149600 is a study of Aortic Valve Disease and Aortic Aneurysm that is active but no longer recruiting, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 1,000 participants, below the 18,550-participant average among 15 other Aortic Valve Disease trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04149600, a study of Aortic Valve Disease and Aortic Aneurysm, is active but no longer recruiting, sponsored by Beth Israel Deaconess Medical Center.

ACTIVE NOT RECRUITING
Registry status
1,000 participants
Enrollment target
1
Study location

Study Summary

This study aims to identify the molecular genetic causes of the variability in development of calcific aortic valve disease in bicuspid and tricuspid aortic valves and their associated aortic dilation.

Interventions

  • PROCEDURE Patients scheduled to undergo aortic valve replacement or aortic surgery at BIDMC will be approached for participation in this study.

Study Locations (1)

Massachusetts

  • Beth Israel Deaconess Medical Center - Boston

Trial Details

FieldValue
Enrollment Target 1,000 participants
Start Date 2018-09-25
Est. Completion 2027-06-30

What the Registry Record Tells You About NCT04149600

The ClinicalTrials.gov registry entry for NCT04149600 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 18,550-participant average among 15 other Aortic Valve Disease trials with a reported enrollment target (95% lower). The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.

The record links to 9 conditions, with Aortic Valve Disease appearing as the primary indexed condition, and to 1 intervention - of which Patients scheduled to undergo aortic valve replacement or aortic surgery at BIDMC will be approached for participation in this study. is the first listed.

NCT04149600 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT04149600 about?

NCT04149600 is a clinical study titled "Identification of Genetic Causes of Calcific Aortic Valve Disease". This study aims to identify the molecular genetic causes of the variability in development of calcific aortic valve disease in bicuspid and tricuspid aortic valves and their associated aortic dilation.

What is the current status of trial NCT04149600?

This trial is currently active not recruiting. The enrollment target is 1,000 participants. The study started on 2018-09-25. Estimated completion is 2027-06-30.

What conditions does trial NCT04149600 study?

This clinical trial studies the following conditions: Aortic Valve Disease, Aortic Aneurysm, Aortic Valve Insufficiency, Aortic Diseases, Aortic Valve Disease Mixed.

What interventions are being tested in trial NCT04149600?

The interventions under investigation include: Patients scheduled to undergo aortic valve replacement or aortic surgery at BIDMC will be approached for participation in this study. (PROCEDURE).

Who is sponsoring clinical trial NCT04149600?

This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04149600 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Aortic Valve Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.